Pharma News Fast track designation to Prothera’s mocravimod for AML patients receiving HSCT Read more
Pharma News FDA approves the frontline use of ivosidenib in AML patients with IDH1 mutation Read more
Pharma News RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leuk... Read more
Pharma News Axicabtagene ciloleucel shows promise as frontline therapy for high-risk large B-cell lymphoma Read more
Pharma News FDA approval for ciltacabtagene autoleucel for Relapsed/Refractory Multiple Myeloma Read more
Pharma News FDA: major safety concerns with Ukoniq, PI3K inhibitor drug for treatment of lymphoma Read more
Top
